Home / Clinical Laboratory / Controls / Control Kit / Antibody Test Control Kit Alinity i SARS-CoV-2 IgG Positive Level / Negative Level 2 X 4 mL06R9010
Picture of Antibody Test Control Kit Alinity i SARS-CoV-2 IgG Positive Level / Negative Level 2 X 4 mL06R9010

Antibody Test Control Kit Alinity i SARS-CoV-2 IgG Positive Level / Negative Level 2 X 4 mL06R9010

Antibody-Test-Control-Kit-Alinity-i-SARS-CoV-2-IgG-Positive-Level--Negative-Level-2-X-4-mL06R9010

SKU #

#1166395

MPN #

06R9010

Brand

Abbott

Stock

In Stock

Quantity

100

Features

CONTROL, ALINITY I SARS-COV-2 IGG (1/EA) D/S

$160.92 USD

Attribute Name Attribute Value
McKesson # 1166395
Manufacturer # 06R9010
Brand Alinity I
Manufacturer Abbott
Application Control Kit
For Use With For Estimation of Test Precision and the Detection of Systematic Analytical Deviations of the Alinity i System when used for the Qualitative Detection of IgG Antibodies to SARS-CoV-2 in Human Serum and Plasma
Levels Positive Level / Negative Level
Product Dating McKesson Acceptable Dating: we will ship >= 90 days
Storage Requirements Requires Refrigeration
Test Name SARS-CoV-2 IgG
Test Type Antibody Test
UNSPSC Code 41116145
Volume 2 X 4 mL

Similar Items

Underarm Crutches McKesson Aluminum Frame Tall Adult 350 lbs. Weight Capacity Push Button - Adjustment

One Size Fits Most White NonSterile Not Rated 8211

In Stock

PR/1 $9.76 USD

Underarm Crutches McKesson Aluminum Frame Tall Adult 350 lbs. Weight Capacity Push Button - Adjustment

One Size Fits Most White NonSterile Not Rated 8211

In Stock

PR/1 $9.76 USD

Underarm Crutches McKesson Aluminum Frame Tall Adult 350 lbs. Weight Capacity Push Button - Adjustment

One Size Fits Most White NonSterile Not Rated 8211

In Stock

PR/1 $9.76 USD

Underarm Crutches McKesson Aluminum Frame Tall Adult 350 lbs. Weight Capacity Push Button - Adjustment

One Size Fits Most White NonSterile Not Rated 8211

In Stock

PR/1 $9.76 USD

  • For use under an Emergency Use Authorization (EUA) Only : https://www.fda.gov/medical-devices/emergency-situations-medical-devices/emergency-use-authorizations
  • Testing is limited to laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) of 1988, 42 U.S.C 263a, to perform moderate or high complexity test
  • Laboratories within the United States and its territories are required to report all positive results to the appropriate public health authorities
  • Negative results do not preclude acute SARS-CoV-2 infection; if acute infection is suspected, direct testing for SARS-CoV-2 is necessary
  • False positive results for SARS-CoV-2 IgG assay may occur due to cross-reactivity from pre-existing antibodies or other possible causes
  • Negative control contains human plasma
  • Positive control contains inactivated, cell-free, human blood-derived material, reactive for anti-SARS-CoV-2 IgG
  • Prescription Use only; For In Vitro Diagnostic Use Only